Reviewing the evidence surrounding preservative-free tafluprost/timolol fixed-dose combination therapy in open-angle glaucoma and ocular hypertension management: a focus on efficacy, safety, and tolerability-Reference-Cited by-同舟云学术

Reviewing the evidence surrounding preservative-free tafluprost/timolol fixed-dose combination therapy in open-angle glaucoma and ocular hypertension management: a focus on efficacy, safety, and tolerability

Published:2022-10-03 Issue:10 Volume:21 Page:1259-1268
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Oddone Francesco¹

Affiliation:

1. Glaucoma Unit, IRCSS-Fondazione Bietti, Roma, Italy

Funder

Santen SA, Switzerland

The Italian Ministry of Health and Fondazione Roma

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2022.2135701

Reference62 articles.

1. Santen UK. Taptiqom 15 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container Summary of product characteristics . 2021. [cited 2021 Feb 15]. Available from: https://medicines.org.uk/emc/product/6917

2. European Glaucoma Society. Terminology and guidelines for glaucoma. 2020 cited 2022 Aug 15]. Available from 2022 Aug 15: https://eugs.org/eng/egs_guidelines_reg.asp?l=1.

3. International Council of Ophthalmology. Guidelines for glaucoma care. 2016 cited 2022 Aug 15]. Available from 2022 Aug 15: https://icoph.org/eye-care-delivery/glaucoma/.

4. Ocular Symptoms and Signs with Preserved and Preservative-Free Glaucoma Medications

5. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preservative-Free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% for Treatment-Naive Patients with Open-Angle Glaucoma;Korean Journal of Ophthalmology;2024-06-05